New & Notable
USPSTF proposes guidelines for cervical cancer screening
With the advent of new self-collection methods for HPV testing, the USPSTF has proposed draft guidelines for cervical cancer screening that include patient-collected HPV tests.
ARPA-H awards startup $3 million for home preeclampsia test
Gravidas Diagnostics received $3 million from ARPA-H to develop a home fingerstick preeclampsia test that detects sFlt‐1 levels in the bloodstream using a colorimetric assay.
2025 life sciences industry outlook: What's next?
A 2025 life sciences industry outlook report identifies several focus areas, including digital transformation, competitive pressures, business volatility and evolving customer needs.
Regulating and monitoring the online GLP-1 market
The booming GLP-1 market is transforming healthcare while raising regulatory concerns, with efforts underway to ensure safety in the online space.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All Reports
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
Pharmacy closures pose risk for minority communities
A study analyzing trends in pharmacy closures found that closures exceeded pharmacy openings between 2018 and 2021, disproportionately impacting marginalized communities.
-
Zepbound outperforms Wegovy in weight loss clinical trial
Researchers comparing the safety and efficacy of Zepbound and Wegovy in a phase 3b clinical trial find that Zepbound might achieve better weight loss results than Wegovy.
-
FDA investigates E. coli outbreak in organic carrots
The FDA is investigating an E. coli outbreak linked to several brands of organic carrots that were recalled by Grimmway Farms for contamination with Shiga toxin-producing E. coli.
-
Over half of Americans won't get the new COVID-19 vaccine
Although over half of Americans do not plan to get the new COVID-19 vaccine for a range of reasons, perceptions vary based on political affiliation, age and race.
-
WHO, CDC report a 20% rise in global measles cases
The WHO and CDC emphasize the need for greater measles surveillance and targeted vaccination efforts to address the 20% rise in global measles cases from 2022 to 2023.
-
CDC estimates a national diabetes prevalence of nearly 16%
A data brief from the CDC focused on the national diabetes prevalence across the U.S. estimates that 16% of adults in the U.S. have diabetes, with approximately 4.5% being undiagnosed.
Features
-
Understanding the impact of food safety recalls, regulation
Food safety regulations are key to protecting public health, ensuring safe consumption and maintaining consumer trust amid complex global food systems.
-
Anticipating the healthcare reach of GLP-1 receptor agonists
Thought leaders at the 2024 WMIF discussed how cost, drug shortages, compounding pharmacies and insurance coverage for GLP-1 receptor agonists will impact the future landscape.
-
Exploring the secondary prevention of cervical cancer
Molecular tests, sampling, cytologic techniques, visual assessment and precancer treatment play a critical tool in the secondary prevention of cervical cancer.
-
Revolutionizing women's health technology through innovation
As more scientists and innovators work toward addressing the gaps in women's healthcare, women's health technology and the ongoing innovation in tech will be critical tools.